News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Nicolas Sayegh: Zeynep Irem Ozay Presented Real-World Data on Lutetium vs. Cabazitaxel in mCRPC at ASCO 2025
Nicolas Sayegh/X
Jun 3, 2025, 17:21

Nicolas Sayegh: Zeynep Irem Ozay Presented Real-World Data on Lutetium vs. Cabazitaxel in mCRPC at ASCO 2025

Nicolas Sayegh, Genitourinary Oncology Research Fellow at Huntsman Cancer Institute, shared an article on X:

“Superstar Zeynep Irem Ozay presenting ASCO our real-world data showing lutetium has better survival outcomes than cabazitaxel in post-ARPI/docetaxel mCRPC patients.”

More posts featuring Nicolas Sayegh and ASCO 2025 on OncoDaily.

ASCO ASCO 2025 ASCO25 cabazitaxel cancer Huntsman Cancer Institute lutetium mCRPC Nicolas Sayegh OncoDaily Oncology Zeynep Irem Ozay
Special Coverage
Blog
Jun 26, 2025, 10:06
Jed Hansen: Nearly Half of All Rural Hospitals in Nebraska Operated at a Loss in 2024
Radiotherapy
Jun 26, 2025, 09:53
Radiotherapy In Pets: Healing Beams for Animals
Science
Jun 26, 2025, 09:52
Routine Childhood Vaccines Saved 154 Million Lives in the Past 50 Years - The Lancet Group
Blog
Jun 26, 2025, 09:48
Andrew M. Evens: Playing With 5-year-old Sirena, Who is Battling Leukemia, Was the Best Part of the Day
Blog
Jun 26, 2025, 09:47
Jan Hirsch: ACPE Board Voted to Grant Full Accreditation Status to the UC Irvine Doctor of Pharmacy Program
Blog
Jun 26, 2025, 09:37
Tune in for The Second Session of the Community 365 Roundtable on Addressing the Challenges of Women and Cancer - ECO
Blog
Jun 26, 2025, 09:36
NCDconnect and ACT for Children: Closing the Paediatric Cancer Gap
Blog
Jun 26, 2025, 09:35
Patrick Hwu: Did You Know Your Eyes Need SPF, Too? 
Blog
Jun 26, 2025, 09:22
Take the AIRSPACE Study Survey: Help to Improve Tobacco Dependency Services - IASLC
Blog
Jun 26, 2025, 09:16
Fredrik Schjesvold: CAR-T for Myeloma is Now Approved in Sweden
Blog
Jun 26, 2025, 09:14
Targeted and Immunotherapy Strategies in NSCLC Explored by ESMO
Insight
Jun 26, 2025, 09:08
Elizabeth McKenna Shared 2025 Study on AAnet Resolving Spatially-Localized Cell States to Unveil Intratumoral Heterogeneity